Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|July 19, 2024
Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 SubpocketMichael Desgagné, Antoine Désilets, Sára Ferková, et al.
European Journal of Medicinal Chemistry|May 18, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitorsSára Ferková, Matthieu Lepage, Antoine Désilets, et al.
Chemmedchem|October 21, 2023
Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus ReplicationÉloïc Colombo, Antoine Désilets, Malihe Hassanzadeh, et al.
Pharmacological Research|January 12, 2025
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitorRebecca L Brouillette, Christine E Mona, Michael Desgagné, et al.
Journal of Medicinal Chemistry|March 22, 2021
Modulation of the Passive Permeability of Semipeptidic Macrocycles: N- and C-Methylations Fine-Tune Conformation and PropertiesChristian Comeau, Benjamin Ries, Thomas Stadelmann, et al.
Journal of Medicinal Chemistry|January 16, 2026
Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site TargetingMargot Hadjadj, Malihe Hassanzadeh, Justin Martel, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit CMaxime Lamontagne Boulet, Charles Isabelle, Isabelle Guay, et al.
Antiviral Research|March 28, 2024
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antiviralsJimena Pérez-Vargas, Gabriel Lemieux, Connor A H Thompson, et al.
Bioorganic & Medicinal Chemistry|December 2, 2025
In vitro and in vivo activity profiles of broad-spectrum bacterial ATP synthase inhibitorsSuzanne Chamberland, Audrey Larose, Guillaume Millette, et al.
Oncotarget|May 16, 2024
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune responseLulzim Shkreta, Johanne Toutant, Aurélie Delannoy, et al.
Pageof 7